FGF2 and hepatocellular carcinoma: In addition, in both hepatocellular carcinoma (HCC) and prostate cancer cells, bFGF was shown to induce epithelial–mesenchymal transition through the AKT/GSK-3β/Snail signaling pathway [15,16].